APA (7th ed.) Citation

S, P., K, H., H, P., J, C., M, R., D, J., . . . TP, B. (2018). Discovery of chiral dihydropyridopyrimidinones as potent, selective and orally bioavailable inhibitors of AKT. Bioorganic & medicinal chemistry letters, 28(10), 1887. https://doi.org/10.1016/j.bmcl.2018.03.092

Chicago Style (17th ed.) Citation

S, Parthasarathy, et al. "Discovery of Chiral Dihydropyridopyrimidinones as Potent, Selective and Orally Bioavailable Inhibitors of AKT." Bioorganic & Medicinal Chemistry Letters 28, no. 10 (2018): 1887. https://doi.org/10.1016/j.bmcl.2018.03.092.

MLA (9th ed.) Citation

S, Parthasarathy, et al. "Discovery of Chiral Dihydropyridopyrimidinones as Potent, Selective and Orally Bioavailable Inhibitors of AKT." Bioorganic & Medicinal Chemistry Letters, vol. 28, no. 10, 2018, p. 1887, https://doi.org/10.1016/j.bmcl.2018.03.092.